Key facts
- It has raised $47.1M; the latest was Grant ($2.0M) in Apr 2026.
- Notable investors include Insight Partners (New York), Oost NL, SHIFT Invest, Radboud University, Siemens Healthineers — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for ScreenPoint Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for ScreenPoint Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ScreenPoint Medical
Developer of a deep learning-based image analysis technology designed for early breast cancer detection. The company's technology enables the early detection and diagnosis of breast cancer to improve accuracy, consistency, and reduce unnecessary recalls, enabling physicians to screen for cancer earlier and make treatment effective and less invasive.
- Sector
- Healthcare
- HQ
- Nijmegen, Netherlands
- Founded
- 2014
- Employees
- 79
- Website
- screenpoint-medical.com/
- Ownership
- Privately Held (backing)
ScreenPoint Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ScreenPoint Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ScreenPoint Medical in its N-PORT filings yet. We sweep new filings monthly.